Iran - Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis
Since 2014, Iran Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis rose 4.4points year on year. In 2019, the country was number 135 among other countries in Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis with 72 Percent. Norway lead the ranking with 108 Percent in 2019, +2.9points versus 2018. Austria, Burundi and Marshall Islands respectively ranked number 2, 3 and 4 in this ranking. Equatorial Guinea witnessed the best average annual growth at +34.3points per year, while United Arab Emirates was the worst growing country at -100points per year.
Loading...
| Date | Percent |
|---|---|
| 2019 | 72.00 |
| 2018 | 70.00 |
| 2017 | 68.00 |
| 2016 | 65.00 |
| 2015 | 63.00 |
Download all data from 2002 to 2019
How does Iran rank in Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis?
| # | 313 Countries | Percent | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Norway
|
108.00 % | 2019 | +2.9 % | +3.7 % | View data | |
| 2 |
#2
Austria
|
107.00 % | 2019 | +4.9 % | +11.2 % | View data | |
| 135 |
#135
Ethiopia
|
72.00 % | 2019 | -1.4 % | +0.6 % | View data | |
| 135 |
#135
Iran
|
72.00 % | 2019 | +2.9 % | +4.4 % | View data | |
| 139 |
#139
Malawi
|
71.00 % | 2019 | +4.4 % | +4.1 % | View data | |